Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end higher on U.S. gains
03/18/2025 05:51 PM - Politics
Army anti-landing exercise held on Day 2 of 'immediate response' drills
03/18/2025 05:50 PM - Politics
Taiwan has rightful place among sovereign nations: Ex-Lithuanian official
03/18/2025 05:11 PM - Business
- Business
U.S. dollar closes lower on Taipei forex market
03/18/2025 04:41 PM